This inventor holds 1 USPTO granted patent. Top assignees: Hankuk University of Foreign Studies Research Business Foundation, Lysentech Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: **Young Deuk Kim: Innovator in Biomedical Research from Seongnam-si, KR**
Introduction
Young Deuk Kim is a prominent inventor located in Seongnam-si, South Korea, known for his significant contributions to biomedical research. With a focus on combating antibiotic-resistant bacteria, his innovations aim to address pressing health issues related to gram-negative pathogens.
Latest Patents
Young Deuk Kim holds a notable patent entitled "Polypeptides and antibiotics against gram-negative bacterium comprising the same." This patent introduces a novel polypeptide demonstrating endolysin activity, along with a fusion protein that incorporates an antibiotic-active protein. The invention provides an effective antibiotic treatment against gram-negative pathogens and offers promising applications in preventing and treating infections and diseases associated with such pathogens.
Career Highlights
Throughout his career, Young Deuk Kim has been associated with reputable organizations, including Lysentech Co., Ltd. and Hankuk University of Foreign Studies Research & Business Foundation. These affiliations reflect his active engagement in research and innovation within the life sciences and biotechnological fields.
Collaborations
Young Deuk Kim has collaborated with several esteemed individuals in the field, including Heejoon Myung and Min Soo Kim. These partnerships highlight the importance of teamwork in advancing research initiatives and achieving groundbreaking results in biomedicine.
Conclusion
In summary, Young Deuk Kim is a dedicated inventor whose work has the potential to make a significant impact on public health. His patent on polypeptides and antibiotics against gram-negative bacteria stands as a testament to innovative approaches in tackling antibiotic resistance. As he continues to contribute to the bioscience community, his efforts will undoubtedly inspire future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile